Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-046495

CEO and Chairman sold 41,035 shares at an average $37.42 ($1,535,408)

  • CEO and Chairman sold 9,005 shares at $38.43 ($346,062)
  • CEO and Chairman acquired 50,040 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
ROBINS CHAD M CEO and Chairman 2020-08-10 Option exercise +16,680 $0.33 $5,504 1,794,860 D
ROBINS CHAD M CEO and Chairman 2020-08-10 Sale −16,680 $37.63 $627,668 1,778,180 D
ROBINS CHAD M CEO and Chairman 2020-08-11 Option exercise +16,680 $0.33 $5,504 1,794,860 D
ROBINS CHAD M CEO and Chairman 2020-08-11 Sale −4,937 $36.51 $180,250 1,789,923 D
ROBINS CHAD M CEO and Chairman 2020-08-11 Sale −9,743 $37.40 $364,388 1,780,180 D
ROBINS CHAD M CEO and Chairman 2020-08-11 Sale −2,000 $37.96 $75,920 1,778,180 D
ROBINS CHAD M CEO and Chairman 2020-08-12 Option exercise +16,680 $0.33 $5,504 1,794,860 D
ROBINS CHAD M CEO and Chairman 2020-08-12 Sale −901 $36.80 $33,157 1,793,959 D
ROBINS CHAD M CEO and Chairman 2020-08-12 Sale −6,774 $37.50 $254,025 1,787,185 D
ROBINS CHAD M CEO and Chairman 2020-08-12 Sale +9,005 $38.43 $346,062 1,778,180 D
Derivatives
ROBINS CHAD M CEO and Chairman 2020-08-10 Option exercise · Stock Option (Right to Buy) −16,680 278,040 D
ROBINS CHAD M CEO and Chairman 2020-08-11 Option exercise · Stock Option (Right to Buy) −16,680 261,360 D
ROBINS CHAD M CEO and Chairman 2020-08-12 Option exercise · Stock Option (Right to Buy) −16,680 244,680 D
Open-market sales · 50,040 sh · avg $37.60 · $1,881,470
Loading xslF345X03/doc4.xml…